These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 1972751

  • 1. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
    Jiang LH, Kasser RJ, Altar CA, Wang RY.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
    [Abstract] [Full Text] [Related]

  • 2. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 3. Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment.
    Hu XT, Wang RY.
    Brain Res; 1989 May 08; 486(2):325-33. PubMed ID: 2786442
    [Abstract] [Full Text] [Related]

  • 4. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 May 08; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 5. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 08; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 6. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 08; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR, Bunney BS.
    J Pharmacol Exp Ther; 1989 Mar 08; 248(3):1323-33. PubMed ID: 2564893
    [Abstract] [Full Text] [Related]

  • 8. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT, Wachtel SR, Galloway MP, White FJ.
    J Neurosci; 1990 Jul 08; 10(7):2318-29. PubMed ID: 1973947
    [Abstract] [Full Text] [Related]

  • 9. One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat.
    Ashby CR, Hitzemann R, Rubinstein JE, Wang RY.
    Brain Res; 1989 Jul 24; 493(1):194-7. PubMed ID: 2570618
    [Abstract] [Full Text] [Related]

  • 10. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain.
    O'Dell SJ, La Hoste GJ, Widmark CB, Shapiro RM, Potkin SG, Marshall JF.
    Synapse; 1990 Jul 24; 6(2):146-53. PubMed ID: 2237777
    [Abstract] [Full Text] [Related]

  • 11. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct 24; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 12. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD, Freeman AS, LeWitt PA, Chiodo LA.
    J Pharmacol Exp Ther; 1990 Oct 24; 255(1):276-84. PubMed ID: 1976800
    [Abstract] [Full Text] [Related]

  • 13. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
    Shen RY, Asdourian D, Chiodo LA.
    Synapse; 1992 Aug 24; 11(4):319-29. PubMed ID: 1354398
    [Abstract] [Full Text] [Related]

  • 14. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 15. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep 07; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens.
    Henry DJ, White FJ.
    J Pharmacol Exp Ther; 1991 Sep 07; 258(3):882-90. PubMed ID: 1890623
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
    Godbout R, Mantz J, Pirot S, Glowinski J, Thierry AM.
    J Pharmacol Exp Ther; 1991 Aug 07; 258(2):728-38. PubMed ID: 1865369
    [Abstract] [Full Text] [Related]

  • 19. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA, Cavalheiro EA, Ikonomidou C, Bortolotto ZA, Klockgether T, Turski L.
    Synapse; 1990 Aug 07; 5(2):113-9. PubMed ID: 2137942
    [Abstract] [Full Text] [Related]

  • 20. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study.
    Hu XT, Wang RY.
    J Neurosci; 1988 Nov 07; 8(11):4340-8. PubMed ID: 2972814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.